All Stories

  1. Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)

    Article • Cytotherapy, January 2024, Elsevier

    Pilar Guerra-Garcia

  2. Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas

    Article • International Journal of Molecular Sciences, May 2023, MDPI AG

    Pilar Guerra-Garcia

  3. Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders

    Article • Blood, April 2023, American Society of Hematology

    Pilar Guerra-Garcia

  4. Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Child...

    Article • Frontiers in Pediatrics, March 2023, Frontiers

    Pilar Guerra-Garcia

  5. Tuberculosis screening after detection of a case in a paediatric haemato-oncology unit in a low prevalence country

    Article • Enfermedades infecciosas y microbiologia clinica (English ed ), October 2022, Elsevier

    Pilar Guerra-Garcia

  6. CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation

    Article • Frontiers in Immunology, August 2022, Frontiers

    Pilar Guerra-Garcia

  7. Advanced Molecular Characterisation in Relapsed and Refractory Paediatric Acute Leukaemia, the Key for Personalised Medicine

    Article • Journal of Personalized Medicine, May 2022, MDPI AG

    Pilar Guerra-Garcia

  8. Experience of a Strategy Including CYP2C19 Preemptive Genotyping Followed by Therapeutic Drug Monitoring of Voriconazole in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation

    Article • Frontiers in Pharmacology, October 2021, Frontiers

    Pilar Guerra-Garcia

  9. A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol

    Article • Trials, October 2021, Springer Science + Business Media

    Pilar Guerra-Garcia

  10. Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)

    Article • EClinicalMedicine, September 2021, Elsevier

    Pilar Guerra-Garcia

  11. The paediatric cancer clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Article • Clinical & Translational Oncology, June 2021, Springer Science + Business Media

    Pilar Guerra-Garcia

  12. Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

    Article • Frontiers in Pediatrics, February 2021, Frontiers

    Pilar Guerra-Garcia

  13. Tuberculosis screening after detection of a case in a paediatric haemato-oncology unit in a low prevalence country

    Article • Enfermedades Infecciosas y Microbiología Clínica, February 2021, Elsevier

    Pilar Guerra-Garcia

  14. Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium

    Article • European Journal of Cancer, December 2020, Elsevier

    Pilar Guerra-Garcia

  15. Clinical outcome of SARS-CoV-2 infection in immunosuppressed children in Spain

    Article • European Journal of Pediatrics, August 2020, Springer Science + Business Media

    Pilar Guerra-Garcia

  16. Inmunoterapia con células CAR-T en hematooncología pediátrica

    Article • Anales de Pediatría, July 2020, Elsevier

    Pilar Guerra-Garcia

  17. Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Article • Clinical & Translational Oncology, May 2020, Springer Science + Business Media

    Pilar Guerra-Garcia

  18. Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: A report from the New Agents Group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Article • May 2020, Research Square

    Pilar Guerra-Garcia

  19. Challenging the indiscriminate use of temozolomide in pediatric high‐grade gliomas: A review of past, current, and emerging therapies

    Article • Pediatric Blood & Cancer, October 2019, Wiley

    Pilar Guerra-Garcia

  20. High-dose etoposide and cyclophosphamide in adults and children with primary refractory and multiply relapsed acute leukaemias: The Royal Marsden experience

    Article • Leukemia Research, October 2019, Elsevier

    Pilar Guerra-Garcia

  21. High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers

    Article • Journal of Medical Genetics, September 2019, BMJ

    Pilar Guerra-Garcia, Francisco Marin

  22. Hipoglucemia como comienzo inusual de un tumor hepático

    Article • Anales de Pediatría, July 2019, Elsevier

    Pilar Guerra-Garcia

  23. Atypical Autoimmune Hematologic Disorders in a Patient With Kabuki Syndrome

    Article • Journal of Pediatric Hematology/Oncology, March 2019, Wolters Kluwer Health

    Pilar Guerra-Garcia

  24. Young Female Donors Do Not Increase the Risk of Graft-versus-Host Disease or Impact Overall Outcomes in Pediatric HLA-Matched Sibling Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, January 2018, Elsevier

    Pilar Guerra-Garcia

  25. Reply to: Role of PET-CT in management of post-transplant lymphoproliferative disorder

    Article • Pediatric Blood & Cancer, October 2017, Wiley

    Pilar Guerra-Garcia

  26. Preliminary experience on the use of PET/CT in the management of pediatric post-transplant lymphoproliferative disorder

    Article • Pediatric Blood & Cancer, June 2017, Wiley

    Pilar Guerra-Garcia

  27. Nueva mutación genética asociada con el síndrome de Pierson

    Article • Anales de Pediatría, December 2016, Elsevier

    Pilar Guerra-Garcia

  28. Neurocutaneous Melanosis: An Illustrative Patient

    Article • Pediatric Neurology, September 2014, Elsevier

    Pilar Guerra-Garcia

  29. Síndrome de Aicardi: estudio retrospectivo de una serie de siete casos

    Article • Revista de Neurología, January 2013, Viguera Editores SLU

    Pilar Guerra-Garcia

  30. Pneumonia with calcified lesion in a child

    Article • Emergency Medicine Journal, June 2012, BMJ

    Pilar Guerra-Garcia